A Study On Cyp2c19 Genetic Variations Of Clopidogrel And Ticagrelor Treatment Among Coronary Artery Disease (CAD) Patients Undergoing Percutaneous Coronary Intervention (PCI)
The P2Y12 receptor inhibitors, especially clopidogrel, are common antiplatelet drugs used for the prevention of recurrent adverse cardiovascular events among patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). Several factors may affect the effectiveness...
Saved in:
Main Author: | Ak-Kaif, Mohammed Ahmed Imran |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | http://eprints.usm.my/60515/1/Pages%20from%20MOHAMMED%20AHMED%20IMRAN%20AK-KAIF%20-%20TESIS.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of percutaneous coronary intervention (PCI) on diastolic dysfunction in coronary artery disease
by: Umar, Bello Tambuwal
Published: (2014) -
A study of aspirin and clopidogrel non-responders in patient undergoing percutaneous coronary intervention (PCI) and associated predictors /
by: Abd Syukur Abdullah
Published: (2009) -
Cost analysis of elective percutaneous coronary intervention and its predictors in Malaysia /
by: Lee, Kun Yun
Published: (2017) -
Open-label randomised controlled study of double dose clopidogrel versus ticagrelor in patients with clopidogrel resistance /
by: Abdul Aziz Marwan
Published: (2013) -
The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
by: Mostafa, Arwa Mohamed Amin
Published: (2016)